Insider filing · ORKA
Carl Dambkowski
Director
profile →
Oruka Therapeutics, Inc.
ORKA · Healthcare · 27 filings in 24 months
ticker →
Carl Dambkowski sold $6.2M of Oruka Therapeutics (ORKA)
Executed May 21, disclosed May 22, 1 day later.
Value, as filed
$6.2M
105,000 sh across 3 lots
Executed
May 21
the trade date, as filed
Disclosed
May 22
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CDCarl Dambkowski (Director) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $6.2M of ORKA (105,000 sh across 3 lots, as filed), executed May 21.
The name
ORKAHealthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Carl Dambkowski in ORKA
ORKASALE
Oruka Therapeutics, Inc.
$2.5M35,000 sh across 2 lots
Exec Jun 11
Filed Jun 12 · 5:30 PM ET